|
|
||||||||
CUTTING EDGE |
Trudeau Institute, Saranac Lake, NY 12983
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
40 days (5). Interestingly, the declining number of resident lung airway memory cells correlates with the declining efficacy of cellular memory against secondary infection, suggesting that these cells play an important role in the control of secondary infections (6). In support of this, lung airway memory T cells have been shown to mediate substantial antiviral activity in a Sendai virus model (7). The underlying mechanism of viral control is not known, but it is likely that early cytokine production may play a key role in reducing viral replication. Despite the role that lung airway memory cells may play in controlling viral infections, they do not proliferate in the lung airways following secondary Sendai virus infection (8, 9). In addition, the majority of CD8+ memory cells in the lung airways express CD11a at low levels which distinguishes them from memory T cells at other sites (8, 10). These observations raise the question of whether CD11alow memory cells in the lung airways are simply end-stage cells or whether they are maintained in a nonproliferative state by the lung environment. To address this issue, we used an adoptive transfer system that allowed direct comparison between the proliferative ability of intratracheally (i.t.)3 and i.v. transferred memory T cells from the lung airways during secondary Sendai virus infection. We demonstrate that memory cells from the lung airways include cells that retain the ability to proliferate and migrate in response to homologous infection when transferred systemically. These data indicate that the lung environment normally limits the expansion of these cells in response to cognate Ag despite the fact that they retain the potential to mediate recall responses to infection.
| Materials and Methods |
|---|
|
|
|---|
Sendai virus (Enders strain) was grown, stored, and titered as previously described (1). Female C57BL/6, B6.Pl-Thy1a/Cy (Thy1.1), and B6.SJL-Ptprca Pep3/BoyJ (CD45.1) mice were purchased from The Jackson Laboratory (Bar Harbor, ME). Animals were housed under specific pathogen-free conditions. Mice (68 wk) were anesthetized by i.p. injection of 2,2,2-tribromoethanol and intranasally infected with 250 50% egg infectious doses (EID50) of Sendai virus.
Bronchoalveolar lavage (BAL)
Mice were anesthetized and then bled by cutting the descending aorta. Lung airway cells were collected by five consecutive 1-ml lavages with HBSS. Cells were adhered on plastic for 1 h and nonadherent cells were collected for FACS analysis. Collected cells were either stained with anti-CD11a PE (BD PharMingen, San Diego, CA) for sorting or CFSE-labeled as described below.
CFSE staining and adoptive transfer of BAL cells
In one set of experiments, Thy1.1+ and CD45.1+ Sendai memory mice were euthanized and lung airway cells were collected as described above. BAL cells were stained with 0.5 µM CFSE for 10 min at room temperature and were washed extensively. Labeled cells were resuspended in 100 µl/HBSS and transferred into naive C57BL/6 recipient mice by i.t. instillation using a blunted and bent 20-gauge needle at a donor to host ratio of 5:1. Recipient mice were then challenged with an intranasal infection with 250 EID50 Sendai virus.
Tissue harvest, preparation, and flow cytometry
BAL were harvested from recipient mice 11 or 12 days postinfection. Harvested cells were stained with allophycocyanin-conjugated tetramer specific for the immunodominant Sendai NP epitope (NP324332/Kb) for 1 h, followed by staining with PerCP-conjugated anti-CD8, and either PE-conjugated anti-Thy1.1 or anti-CD45.1 Abs for 20 min and fixed overnight. Stained samples were analyzed as described below. In other experiments, BAL cells were collected, plastic-adhered, and stained with anti-CD11a PE for 20 min. Stained cells were sorted into CD11ahigh and CD11alow populations on a FACSVantage cell sorter (BD Immunocytometry Systems, San Jose, CA) with diva enhancement software, CFSE-labeled, and transferred into naive recipients as above or sorted cells were transferred without CFSE and stained as above with the exception of the addition of anti-CD11a FITC in place of CFSE.
Flow cytometry
MHC class I-peptide tetramers were generated by the Molecular Biology Core Facility (Trudeau Institute, Saranac Lake, NY) as described previously (11). Cells were stained with NP324332/Kb allophycocyanin-specific tetramer for 1 h at room temperature as previously described (5). Tetramer-labeled cells were then stained with anti-CD8 PerCP and FITC-conjugated mAbs specific for CD11a, and PE-conjugated mAbs specific for Thy1.1 (BD PharMingen, San Diego, CA) or CD45.1 (eBioscience, San Diego, CA) on ice for 20 min and fixed overnight with 1% paraformaldehyde in PBS. Samples were run on a BD Biosciences FACSCalibur flow cytometer (San Jose, CA) and data were analyzed using FlowJo software (Treestar, San Carlos, CA). The percentage of tetramer-positive cells among CD8+ T cells was calculated by dividing the number of tetramer-positive CD8+ events by the total number of events in the CD8+ gate. The absolute number of tetramer-positive cells was calculated using the percentage of tetramer-positive cells among the total live cell gate and the number of cells isolated per mouse in each tissue as indicated by trypan blue staining.
| Results and Discussion |
|---|
|
|
|---|
To analyze the functional capacity of lung airway memory cells, the BAL was collected from CD45.1+ congenic donor mice that had recovered from a Sendai virus infection. The cells were plastic-adhered and nonadherent cells were CFSE-labeled and i.v. transferred into CD45.2+ naive recipient mice. One day later, recipient mice were intranasally infected with a sublethal dose of Sendai virus. Eleven days postinfection (12 days posttransfer), the recipient mice were killed and cells from lung airways and lung parenchyma, draining lymph node, and spleen were isolated and examined for the presence of donor (CD45.1+) NP324332/Kb-specific memory T cells. As shown in Fig. 1, donor memory T cells were found in the lung airways, lung parenchyma, draining lymph node, and the spleen 12 days posttransfer. All of the recovered cells expressed low levels of CFSE indicating that they had proliferated extensively following Sendai virus infection of the recipient. Consistent with this, the number of cells recovered had increased from an input of
4,600 NP324332/Kb-specific T cells to >30,000 cells in the lungs, mediastinal lymph node (MLN) and spleen combined by 12 days posttransfer. This level of expression was similar to that observed using splenocytes from mice that had recovered from Sendai virus infection as donor cells (an average 20-fold expansion of Ag-specific donor cells with no expansion observed during an irrelevant influenza infection, data not shown). In addition, we also found that i.v.-transferred lung airway memory cells could be detected in the lung airways 36 days posttransfer (data not shown) indicating that these cells develop into lung airway resident memory T cells following resolution of the infection. These results demonstrate that lung airway resident memory CD8+ T cells retain the ability to proliferate and migrate in response to homologous infection following systemic transfer.
|
20,000 NP324332/Kb-specific cells detected in the lung airways 11 days post-Sendai virus infection), we were unable to detect i.t.-transferred cells. These data are consistent with previous studies showing that i.t.-transferred memory cells do not expand in the lung following viral challenge and are deleted during the acute inflammatory response (7, 8, 9). Thus, these results suggest the lung environment controls the proliferative capacity and survival of these memory cells.
|
The previous data demonstrate that lung airway memory cells are able to proliferate when removed from the lung environment. However, it is possible that the data in Fig. 1 represent the outgrowth of a small percentage of contaminating cells from the lung parenchyma or recent immigrants that express high levels of CD11a (5). Indeed, we have recently shown that recent arrivals to the lung airway express higher levels of CD11a and then progressively lose this high expression over time (8). To address this issue, we isolated lung airway memory cells from CD45.1+ donor mice that expressed low levels of CD11a by FACS. Sorted CD11alow cells were then i.v. transferred into C57BL/6 (CD45.2+) recipient mice and intranasally infected with Sendai virus as described above. Donor cells were recovered from the airways and parenchymal tissue of the lung, as well as, draining lymph node and spleen on day 11 post-Sendai virus infection. As demonstrated in Fig. 3, columns A and B, the transferred CD11alow Sendai memory cells proliferated in response to homologous infection as shown by the decrease in CFSE intensity. This proliferation resulted in a 5-fold increase in the total number of NP324-332/Kb-specific donor T cells recovered from recipient mice (Table I). These data confirm that CD11alow memory cells in the lung airways retain the ability to mediate recall responses by proliferating and migrating to the site of infection following Sendai virus challenge. Furthermore, the data indicate that i.v.-transferred CD11alow lung airway memory T cells isolated 11 days after Sendai virus infection up-regulated CD11a in all tissues examined (Fig. 4). CD11a is an adhesion and activation marker that is involved in the extravasation of cells out of the circulation. The loss or blockade of this molecule can impair T cell trafficking. For example, pretreatment of transferred effector cells with anti-LFA-1 Ab resulted in decreased endothelial cells adhesion and retention of transferred cells in the lung compared with control treated animals (12). Thus, the re-expression of CD11a on i.v.-transferred BAL cells may account for their ability to migrate throughout the recipient host.
|
|
|
Taken together, the data show that lung airway resident memory T cells retain the potential to proliferate, re-express CD11a, and migrate to the site of infection in the lung airways following i.v. transfer indicating that they are not terminally differentiated cells. However, these same cells failed to proliferate and persist when placed directly into the lung airways suggesting that the lung environment is not permissive for the proliferation of these cells. In this regard, it has been reported that local factors, such as lung surfactants may inhibit the proliferation of T cells in the lung (19, 20, 21, 22). It is possible that inhibition of T cell proliferation in nonlymphoid tissues is an important mechanism to avoid inappropriate or dysregulated T cell response. Thus, it may be the case that T cell proliferation is always restricted to lymphoid tissues to ensure appropriate regulation of the response. Furthermore, the failure of T cells proliferate in the lung airways suggests that the size of the memory deposited in the lung airways is a function of the magnitude of recruitment to the airways during resolution of the infection. This hypothesis, along with the observation that lung airway memory cells are able to mediate recall responses, has implications for the development of vaccines designed to promote cellular immunity in the lung.
| Acknowledgments |
|---|
| Footnotes |
|---|
2 Address correspondence and reprint requests to Dr. David L. Woodland, Trudeau Institute, 100 Algonquin Avenue, P.O. Box 59, Saranac Lake, NY 12983. E-mail address: dwoodland{at}trudeauinstitute.org ![]()
3 Abbreviations used in this paper: i.t., intratracheal; BAL, bronchoalveolar lavage; EID50, 50% egg infectious dose; MLN, mediastinal lymph node. ![]()
Received for publication July 2, 2003. Accepted for publication August 11, 2003.
| References |
|---|
|
|
|---|
. Adv. Exp. Med. Biol. 512:165.[Medline]
This article has been cited by other articles:
![]() |
F. Masson, T. Calzascia, W. Di Berardino-Besson, N. de Tribolet, P.-Y. Dietrich, and P. R. Walker Brain Microenvironment Promotes the Final Functional Maturation of Tumor-Specific Effector CD8+ T Cells J. Immunol., July 15, 2007; 179(2): 845 - 853. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Santosuosso, S. McCormick, E. Roediger, X. Zhang, A. Zganiacz, B. D. Lichty, and Z. Xing Mucosal Luminal Manipulation of T Cell Geography Switches on Protective Efficacy by Otherwise Ineffective Parenteral Genetic Immunization J. Immunol., February 15, 2007; 178(4): 2387 - 2395. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Obhrai, M. H. Oberbarnscheidt, T. W. Hand, L. Diggs, G. Chalasani, and F. G. Lakkis Effector T Cell Differentiation and Memory T Cell Maintenance Outside Secondary Lymphoid Organs J. Immunol., April 1, 2006; 176(7): 4051 - 4058. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Masopust, V. Vezys, E. J. Wherry, D. L. Barber, and R. Ahmed Cutting Edge: Gut Microenvironment Promotes Differentiation of a Unique Memory CD8 T Cell Population J. Immunol., February 15, 2006; 176(4): 2079 - 2083. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. H. Ely, T. Cookenham, A. D. Roberts, and D. L. Woodland Memory T Cell Populations in the Lung Airways Are Maintained by Continual Recruitment J. Immunol., January 1, 2006; 176(1): 537 - 543. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. E. West, T. L. Lavoie, J. B. Orens, E. S. Chen, S. Q. Ye, F. D. Finkelman, J. G. N. Garcia, and J. F. McDyer Pluripotent Allospecific CD8+ Effector T Cells Traffic to Lung in Murine Obliterative Airway Disease Am. J. Respir. Cell Mol. Biol., January 1, 2006; 34(1): 108 - 118. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. Bachmann, P. Wolint, K. Schwarz, and A. Oxenius Recall Proliferation Potential of Memory CD8+ T Cells and Antiviral Protection J. Immunol., October 1, 2005; 175(7): 4677 - 4685. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. Bachmann, P. Wolint, K. Schwarz, P. Jager, and A. Oxenius Functional Properties and Lineage Relationship of CD8+ T Cell Subsets Identified by Expression of IL-7 Receptor {alpha} and CD62L J. Immunol., October 1, 2005; 175(7): 4686 - 4696. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Woodland and I. Scott T Cell Memory in the Lung Airways Proceedings of the ATS, August 1, 2005; 2(2): 126 - 131. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D. Roberts, K. H. Ely, and D. L. Woodland Differential contributions of central and effector memory T cells to recall responses J. Exp. Med., July 5, 2005; 202(1): 123 - 133. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Santosuosso, X. Zhang, S. McCormick, J. Wang, M. Hitt, and Z. Xing Mechanisms of Mucosal and Parenteral Tuberculosis Vaccinations: Adenoviral-Based Mucosal Immunization Preferentially Elicits Sustained Accumulation of Immune Protective CD4 and CD8 T Cells within the Airway Lumen J. Immunol., June 15, 2005; 174(12): 7986 - 7994. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Unsoeld and H. Pircher Complex Memory T-Cell Phenotypes Revealed by Coexpression of CD62L and CCR7 J. Virol., April 1, 2005; 79(7): 4510 - 4513. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-J. Lee, L. Myers, G. Muralimohan, J. Dai, Y. Qiao, Z. Li, R. S. Mittler, and A. T. Vella 4-1BB and OX40 Dual Costimulation Synergistically Stimulate Primary Specific CD8 T Cells for Robust Effector Function J. Immunol., September 1, 2004; 173(5): 3002 - 3012. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D. Roberts and D. L. Woodland Cutting Edge: Effector Memory CD8+ T Cells Play a Prominent Role in Recall Responses to Secondary Viral Infection in the Lung J. Immunol., June 1, 2004; 172(11): 6533 - 6537. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Castro, S. R. Bloch, M. V. Jenkerson, S. DeMartino, D. L. Hamilos, R. B. Cochran, X. E. L. Zhang, H. Wang, J. P. Bradley, K. B. Schechtman, et al. Asthma Exacerbations after Glucocorticoid Withdrawal Reflects T Cell Recruitment to the Airway Am. J. Respir. Crit. Care Med., April 1, 2004; 169(7): 842 - 849. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |